Haohai Biotec (06826) has released its results for the first three quarters of 2026, reporting operating revenue of approximately 1.71 billion yuan, a year-on-year decrease of 9.93%.

Net profit attributable to shareholders of the listed company was approximately 163 million yuan, down 46.53% compared with the same period last year.

Basic earnings per share came in at 0.71 yuan.